NS Pharma, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1999-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.nspharma.com
Capricor Therapeutics Announces Positive 3-Year Efficacy Results from HOPE-2 Study of CAP-1002 for Duchenne Muscular Dystrophy
Capricor Therapeutics reported positive 3-year results from the HOPE-2 study of CAP-1002 for Duchenne Muscular Dystrophy, showing benefits in skeletal muscle function and cardiac function stabilization. Results were shared with the FDA, supporting CAP-1002's long-term impact and safety profile.
© Copyright 2025. All Rights Reserved by MedPath